BRUNSWICK & PORTLAND, ME – July 2, 2025 – Salmonics, a pioneering provider of biomedical products derived from fish proteins, has become an inaugural member of the BioPILOT Lab, a program of Northeastern University’s Roux Institute in Portland, Maine. The company will leverage this opportunity to refine its technology and enhance the development of its groundbreaking blocking buffers, protein-based reagents, and 3D cell culture matrices.
The BioPILOT Lab supports Maine-based biotech companies by offering access to shared lab space and cutting-edge equipment for research in cell biology, microbiology, biochemistry, and molecular biology. As a member, Salmonics will benefit from the use of advanced instruments such as an Agilent BioAnalyzer and multi-mode plate reader, as well as collaborative support from the Roux Institute’s and University of Southern Maine (USM)’s esteemed faculty and research community. The BioPILOT Lab is co-located with the BioIN incubator program in the USM Science Building in Portland.
Salmonics’ initial 12-month BioPILOT membership is funded through the Maine Technology Institute, reinforcing the state’s commitment to growing its biotechnology sector. During this time, Salmonics will focus on refining its proprietary Sea Block® Blocking Buffer, a fish-based blocking solution designed to improve laboratory performance in ELISA, Western Blot, IHC, and fluorescence assays. By leveraging fish-derived proteins, Sea Block® reduces the noise and cross-reaction associated with mammalian samples, delivering more reliable and clearer results for scientists.
In addition to advancing its flagship product, Salmonics will explore new frontiers in protein research and 3D cell culture development. These efforts aim to strengthen data acquisition and quality control in the company’s Fibrinogen and Thrombin product lines while accelerating the upcoming launch of Fibronectin and other new products.
“Membership in the BioPILOT Lab marks an exciting milestone for Salmonics as we expand our research and product development capabilities and continue bringing novel, sustainable solutions to laboratories,” said Salmonics Founder, CEO, and President, Dr. Cem Giray. “With the support of the Roux Institute’s expert community and access to equipment currently unavailable in our facilities, we’re positioned to accelerate innovation and deliver better tools for researchers everywhere.” Salmonics researchers are already undergoing training and actively utilizing the shared facilities at the Roux Institute. This collaboration represents another key step in Salmonics’ mission to advance life sciences and biotechnology in Maine and beyond.
“Salmonics exemplifies the kind of innovative, mission-driven company we’re proud to support at the BioPILOT Lab,” said Marsha Rolle, Director of the BioPILOT Lab. “Their pioneering use of fish-derived proteins aligns perfectly with our vision of sustainable, next-generation biotechnology. We’re excited to provide them with the resources and collaborative environment needed to accelerate their research and bring transformative products to market.”
Salmonics continues to unlock the research and therapeutic potential of fish-derived proteins. To learn more about the company’s breakthroughs and explore its high-quality product line, visit www.salmonics.co.
About Salmonics:
Salmonics is a Maine-based biotechnology company advancing a new frontier in biomedical innovation through sustainable, fish-derived research tools and therapeutics. The company’s foundation stems from the pioneering work of Sea Run Holdings Inc. (SRH), established in 1981 by Dr. Evelyn S. Sawyer. SRH transformed biomedical research with the discovery of the potent therapeutic properties of salmon plasma proteins, particularly fibrinogen and thrombin. These fish proteins exhibit powerful hemostatic properties and deliver unprecedented, long-lasting pain relief, surpassing even morphine in preclinical studies. Today, under the leadership of Dr. Cem Giray, Salmonics carries forward this legacy by developing next-generation solutions for life science research, wound healing, pain management, and trauma care, all while harnessing a renewable resource with vast clinical and research potential. Learn more at https://www.salmonics.co/
About The Roux Institute:
Northeastern University’s Roux Institute is a bold new model that erases the boundaries between the real world and the university, integrating learning, research, innovation, and entrepreneurship to create a powerful opportunity engine. To learn more, visit www.roux.northeastern.edu.
